Print

HVTN 072

A Phase 1B Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Adenoviral Serotype 35 (rAd35) and Serotype 5 (rAd5) HIV-1 Vaccines When Given in Heterologous Prime-Boost Regimens or as a Boost to a Recombinant DNA Vaccine in Healthy

Trial Details:

Ib Completed
HVTN, National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) August 08, 2007
VRC-HIVADV038-00-VP,VRC-HIVADV027-00-VP,VRC-HIVDNA044-00-VP Ad5 env A; Ad35 Env A; DNA Env A
VRC-HIVDNA044-00-VP DNA
VRC-HIVADV027-00-VP Viral Vector - Adeno
VRC-HIVADV038-00-VP Viral Vector - Adeno
USA 204
NCT00472719
http://clinicaltrials.gov/ct/show/NCT00472719?order=1